• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂(PPI)的使用对偏头痛的影响——一项批判性综述。

Effects of proton pump inhibitor (PPI) use on migraine - a critical review.

作者信息

Tischler-Strasser Viktoria, Burdiladze Irma, Cabral Goncalo, Ekizoglu Esme, Grodzka Olga, Pardo Keshet, Sochan Patryk, Zaunandra Laura, MaassenVanDenBrink Antoinette, Lampl Christian

机构信息

Department of Neurology, Koventhospital Barmherzige Brüder, Linz, Austria.

Headache Medical Center Linz, Seilerstätte 2, Linz, Austria.

出版信息

J Headache Pain. 2025 Jan 30;26(1):20. doi: 10.1186/s10194-025-01954-z.

DOI:10.1186/s10194-025-01954-z
PMID:39885408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11783727/
Abstract

BACKGROUND

Proton pump inhibitor (PPI) drugs are widely used and are among the most significant achievements of modern pharmacology. Their primary purpose is treating and preventing gastric acid-related disorders. Migraine and PPI intake are prevalent, and many people are affected by both. In the last few years, a potential link between PPI intake and the development of headaches-especially migraine-has come to increased attention. In this review, we critically examine the scientific data concerning the co-occurrence of these two entities.

FINDINGS

There seems to be a possible link between the use of PPIs and the occurrence of headache, especially migraine, suggesting a pathophysiological connection on several levels. Moreover, PPI use is only partially without side effects, even if these may not occur immediately. Whether the relation is causative or merely co-existential is currently not yet clear. The influence of genetics, environment, gut microbiome, medication intake and evolution of headache is multidirectional.

CONCLUSION

A relation between the prevalence of migraine and the use of PPIs on a population and personal level seems likely. Although PPIs have many advantages, they should be prescribed with caution, especially in patients who suffer from headaches and migraine. In this narrative review, we aim to critically evaluate existing data and offer a potential approach to accurately identify any connections and interactions, leading to a better understanding of how these conditions may influence each other.

摘要

背景

质子泵抑制剂(PPI)药物被广泛使用,是现代药理学最重要的成果之一。其主要目的是治疗和预防与胃酸相关的疾病。偏头痛和PPI的使用都很普遍,许多人同时受这两种情况影响。在过去几年中,PPI的使用与头痛尤其是偏头痛的发生之间的潜在联系受到了越来越多的关注。在本综述中,我们批判性地审视了有关这两种情况同时出现的科学数据。

研究结果

PPI的使用与头痛尤其是偏头痛的发生之间似乎存在可能的联系,这表明在多个层面上存在病理生理联系。此外,即使PPI的副作用可能不会立即出现,其使用也并非完全没有副作用。目前尚不清楚这种关系是因果关系还是仅仅是共存关系。遗传、环境、肠道微生物群、药物摄入和头痛的演变之间的影响是多方向的。

结论

在人群和个体层面上,偏头痛的患病率与PPI的使用之间似乎存在关联。尽管PPI有许多优点,但在开药时应谨慎,尤其是对于患有头痛和偏头痛的患者。在本叙述性综述中,我们旨在批判性地评估现有数据,并提供一种潜在的方法来准确识别任何联系和相互作用,从而更好地理解这些情况可能如何相互影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/0238f707cb4b/10194_2025_1954_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/bef13fcceae6/10194_2025_1954_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/572c4e701e41/10194_2025_1954_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/5eef72b6ea0e/10194_2025_1954_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/e383d5732619/10194_2025_1954_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/9bbfea10ff69/10194_2025_1954_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/0238f707cb4b/10194_2025_1954_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/bef13fcceae6/10194_2025_1954_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/572c4e701e41/10194_2025_1954_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/5eef72b6ea0e/10194_2025_1954_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/e383d5732619/10194_2025_1954_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/9bbfea10ff69/10194_2025_1954_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3aa/11783727/0238f707cb4b/10194_2025_1954_Fig6_HTML.jpg

相似文献

1
Effects of proton pump inhibitor (PPI) use on migraine - a critical review.质子泵抑制剂(PPI)的使用对偏头痛的影响——一项批判性综述。
J Headache Pain. 2025 Jan 30;26(1):20. doi: 10.1186/s10194-025-01954-z.
2
Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank.英国生物库中偏头痛患病率、质子泵抑制剂治疗与 CYP2C19 表型的相关性。
Biomed Pharmacother. 2021 Nov;143:112234. doi: 10.1016/j.biopha.2021.112234. Epub 2021 Sep 30.
3
Association between proton pump inhibitor use and migraine: a systematic review and meta-analysis.质子泵抑制剂的使用与偏头痛之间的关联:一项系统评价和荟萃分析。
J Headache Pain. 2025 Mar 28;26(1):63. doi: 10.1186/s10194-025-02000-8.
4
Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.质子泵抑制剂相关性头痛:台湾一项基于全国人群的病例交叉研究
Cephalalgia. 2015 Mar;35(3):203-10. doi: 10.1177/0333102414535114. Epub 2014 May 22.
5
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.长期使用质子泵抑制剂(PPI)与胃前驱病变的发生
Cochrane Database Syst Rev. 2014 Dec 2;2014(12):CD010623. doi: 10.1002/14651858.CD010623.pub2.
6
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.质子泵抑制剂在酸相关性疾病中的有效与安全治疗——一份探讨抑酸益处及潜在危害的立场文件
BMC Med. 2016 Nov 9;14(1):179. doi: 10.1186/s12916-016-0718-z.
7
Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.与部署相关的脑震荡后,预先存在的偏头痛和其他合并症或共病对表现和临床过程的影响。
Headache. 2020 Mar;60(3):526-541. doi: 10.1111/head.13709. Epub 2020 Jan 3.
8
The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: a pilot study.罗伊氏乳杆菌 LR06、戊糖片球菌 LPS01、植物乳杆菌 LP01 和德氏乳杆菌亚种保加利亚乳杆菌 LDD01 恢复慢性 PPI 治疗患者“胃屏障效应”的创新潜力:一项初步研究。
J Clin Gastroenterol. 2012 Oct;46 Suppl:S18-26. doi: 10.1097/MCG.0b013e318267b55d.
9
Association and Mechanisms of Proton Pump Inhibitors Use with Type-2Diabetes Mellitus Incidence in Adults: A Systemic Review andMeta-Analysis.质子泵抑制剂的使用与成年人 2 型糖尿病发病率的关联及其机制:系统评价和荟萃分析。
Curr Diabetes Rev. 2024;20(10):e120124225581. doi: 10.2174/0115733998254869231101095222.
10
Use of Acid-Suppression Therapy and Odds of Migraine and Severe Headache in the National Health and Nutrition Examination Survey.在国家健康与营养检查调查中酸抑制疗法的使用与偏头痛及严重头痛的几率
Neurol Clin Pract. 2024 Jun;14(3):e200302. doi: 10.1212/CPJ.0000000000200302. Epub 2024 Apr 24.

本文引用的文献

1
Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density.长期质子泵抑制剂对磷钙代谢和骨密度的影响。
Future Sci OA. 2024 May 24;10(1):FSO977. doi: 10.2144/fsoa-2023-0198. eCollection 2024.
2
Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study.健康受试者中阿托格潘与葡萄糖酸奎尼丁联合给药的药代动力学和安全性:一项1期开放标签药物相互作用研究。
Clin Pharmacol Drug Dev. 2024 Aug;13(8):930-937. doi: 10.1002/cpdd.1407. Epub 2024 May 3.
3
Use of Acid-Suppression Therapy and Odds of Migraine and Severe Headache in the National Health and Nutrition Examination Survey.
在国家健康与营养检查调查中酸抑制疗法的使用与偏头痛及严重头痛的几率
Neurol Clin Pract. 2024 Jun;14(3):e200302. doi: 10.1212/CPJ.0000000000200302. Epub 2024 Apr 24.
4
Epidemiology of migraine.偏头痛的流行病学。
Handb Clin Neurol. 2023;198:31-38. doi: 10.1016/B978-0-12-823356-6.00017-2.
5
Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity.质子泵抑制剂(PPI)相关的代谢不健康肥胖中的菌群失调的证据。
Front Endocrinol (Lausanne). 2023 Jun 15;14:1205490. doi: 10.3389/fendo.2023.1205490. eCollection 2023.
6
Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease.质子泵抑制剂使用对炎症性肠病患者临床结局的影响。
Ann Med. 2023 Dec;55(1):2198775. doi: 10.1080/07853890.2023.2198775.
7
Migraine: from pathophysiology to treatment.偏头痛:从病理生理学到治疗。
J Neurol. 2023 Jul;270(7):3654-3666. doi: 10.1007/s00415-023-11706-1. Epub 2023 Apr 8.
8
A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens.通过CYP2C19药物遗传学视角重新审视质子泵抑制剂(PPI)相关不良事件。
Expert Opin Drug Metab Toxicol. 2023 Feb;19(2):53-56. doi: 10.1080/17425255.2023.2190883. Epub 2023 Mar 23.
9
Association between Migraines and Prior Proton Pump Inhibitor Use: A Nested Case-Control Study Using a National Health Screening Cohort.偏头痛与既往质子泵抑制剂使用之间的关联:一项基于全国健康筛查队列的巢式病例对照研究。
Pharmaceuticals (Basel). 2022 Nov 10;15(11):1385. doi: 10.3390/ph15111385.
10
Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.降钙素基因相关肽在偏头痛胃肠道症状中的作用:临床思考:一篇叙述性综述。
Neurology. 2022 Nov 7;99(19):841-853. doi: 10.1212/WNL.0000000000201332.